DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Giugliano D, Maiorino MI, Bellastella G. et al.
GLP-1 receptor agonists for prevention of cardiorenal outcomes in type 2 diabetes: an updated meta-analysis including the REWIND and PIONEER 6 trials.
Diabetes Obes Metab 2019;
21 (11) 2576-2580
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.